(Courtesy of Getty Images) Cosmetics and beauty shares are benefiting from president-elect Yoon Seok-yeol’s pledge to ease social distancing mandates. South Korean cosmetics stocks, undervalued given their recent price plunges, are expected to rally thanks to investors betting on relaxed pandemic-related restrictions.
Skincare giant Cosmax Inc., original design manufacturer (ODM) for global brands such as L'Oréal, and Johnson & Johnson, closed at 82,300 won ($67.24) on March 25, up 1.35%. The stock price rebounded by around 21% from its 52-week low of 68,000 won ($55.56) on Jan. 28, boosted by reopening expectations.
Major ODM Kolmar Korea Co., a supplier to Estee Lauder and other global big brands, closed at 41,950 won on Friday, with a 23.7% jump from a 52-week low of 33,900 won on Jan. 28. ODMs are said to be sensitive to market changes, garnering attention when demand increases. Another makeup ODM C&C International Co. is also expected to benefit.
When expectations on reopening shares increased, cosmetics & beauty stocks fluctuated as demand for cosmetic products remained sluggish due to mask-wearing regulations. President-elect Yoon is considering repealing mask mandates outdoors, which could be favorable for cosmetics shares. Recovery in the travel sector also could benefit cosmetics sales in duty-free shops.
Undervalued stocks of cosmetics firms are already attracting investors. The 12-month forward price-to-earnings ratio of conglomerate Amorepacific Corp. is 31.3 times, much lower than 50 times a year ago. Cosmax’s 12-month P/E ratio is 9.8 times, nearly half the 19.1 times of a year ago. The stocks will enjoy stable growth in Korean and Chinese markets in line with the economic recovery, said Korea Investment & Securities Co. analyst Kim Myung-joo.
Write to Yun-Sang Ko at kys@hankyung.com Jihyun Kim edited this article.
We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.